AdComplyRx Industry POV on the latest 2020 FDA Warning Letter that the Office of Prescription Drug Promotion (OPDP) issued for non-compliant paid search engine marketing (SEM) text ads for ProCentra (adhd med) on Google.

POV Includes:

What Happened?

Why is this Important?

What specifically was cited in the Letter?

Recommendations